What can large-scale metabolomic and genetic profiling of population biobanks tell us about common disease?
Dr Luke Jostins-Dean, Group Leader, Kennedy Institute of Rheumatology and Principal Scientist at Nightingale Health UK, and Dr Eirini Trichia, Senior Statisical Epidemiologist, Oxford Population Health
Tuesday, 23 January 2024, 9.30am to 10.30am
BDI/OxPop Building, LG seminar room 1
Talk 1: 9:30am – 9:50am
Dr Luke Jostins-Dean
Predicting common diseases in large biobanks with metabolic and polygenic risk scores
Talk 2: 9:50am – 10:10am
Dr Eirini Trichia
Leveraging physiological and metabolomic traits to understand the genetic basis of type 2 diabetes in a Mexican population.